Drug discovery expertise at GTx positions the company well to sustain its established clinical pipeline through the design and development of nonsteroidal small molecule drugs that modulate hormone receptors:

• Discovery and development expertise from our staff of medicinal chemists and discovery scientists
• Dynamic, structure-based SARMs modeling program
• Hydrated androgen receptor as template
• Predicts structure-activity relationships confirmed in vivo